1. 唐本忠 中国 香港中文大学（深圳） 中国科学院院士 Type I AIE photosensitizers: Mechanism and application
2. 谭蔚泓 中国 上海交通大学 中国科学院院士 Computer-aided design of reversible hybridization chain reaction (CAD-HCR) enables multiplexed singl..
3. Altman, Russ Biagio 美国 Stanford University 2009美国医学院院士 Distinct clinical phenotypes for Crohn's disease derived from patient surveys
4. 赵玉沛 中国 中国医学科学院 中国科学院院士 Mucins in pancreatic cancer: A well-established but promising family for diagnosis, prognosis and th..
5. 卞修武 中国 陆军军医大学 中国科学院院士 Ribosomal S6 protein kinase 4 promotes radioresistance in esophageal squamous cell carcinoma
6. 段树民 中国 浙江大学 中国科学院院士 mTOR-mediated metabolic reprogramming shapes distinct microglia functions in response to lipopolysac..
7. Fisher, David E. 美国 Massachusetts General Hospital 2020美国医学院院士 The lncRNA RMEL3 protects immortalized cells from serum withdrawal-induced growth arrest and promote..
8. 孙颖浩 中国 海军军医大学 中国工程院院士 Gankyrin is a novel biomarker for disease progression and prognosis of patients with renal cell carc..
9. Curran, Tom 美国 Children's Mercy, Kansas City 2009美国医学院院士 Reproducibility of academic preclinical translational research: lessons from the development of Hedg..
10. Michael Karin 美国 University of California, San Diego 2011美国医学院院士;2005美国科学院院士 p62/SQSTM1Dr. Jekyll and Mr. Hyde that prevents oxidative stress but promotes liver cancer
11. Matthew J,Ellis 美国 Baylor College of Medicine The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer
12. Andrea B,Apolo 美国 National Cancer Institute The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer
13. Yair,Lotan 美国 University of Texas Southwestern Medical Center The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer
14. Seth P,Lerner 美国 Baylor College of Medicine The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer
15. Chad J,Creighton 美国 Baylor College of Medicine The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer
16. Solomon,Habtemariam 英国 University of Greenwich Oridonin from Rabdosia rubescens: An emerging potential in cancer therapy - A comprehensive r..
17. Javad,Sharifi-Rad 伊朗 SHAHID BEHESHTI UNIVERSITY MEDICAL SCIENCES Oridonin from Rabdosia rubescens: An emerging potential in cancer therapy - A comprehensive r..
18. Irish, Jonathan C. 加拿大 University of Toronto The impact of surgical resection margins on outcomes for adults with head and neck osteosarcomas: A ..
19. Goldstein, David P. 加拿大 University of Toronto The impact of surgical resection margins on outcomes for adults with head and neck osteosarcomas: A ..
20. O'Sullivan, Brian 加拿大 University of Toronto The impact of surgical resection margins on outcomes for adults with head and neck osteosarcomas: A ..